Inmed Pharmaceuticals Stock Momentum Indicators Stochastic Relative Strength Index

INM Stock  USD 5.26  0.11  2.14%   
InMed Pharmaceuticals momentum indicators tool provides the execution environment for running the Stochastic Relative Strength Index indicator and other technical functions against InMed Pharmaceuticals. InMed Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Stochastic Relative Strength Index indicator function is designed to identify and follow existing trends. Momentum indicators of InMed Pharmaceuticals are pattern recognition functions that provide distinct formation on InMed Pharmaceuticals potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify the following input to run this model: Time Period, Fast-K Period, Fast-D Period, and Fast-D MA.

The output start index for this execution was sixteen with a total number of output elements of fourty-five. The Stochastic Relative Strength Index compares InMed Pharmaceuticals closing price in relationship to its price range over a given period of time. When the InMed Pharmaceuticals SRSI reaches up above the upper threshold line, the equity is considered overbought with anticipation a reversal of InMed Pharmaceuticals trend.

InMed Pharmaceuticals Technical Analysis Modules

Most technical analysis of InMed Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for InMed from various momentum indicators to cycle indicators. When you analyze InMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About InMed Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InMed Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of InMed Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing InMed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InMed Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of InMed Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for InMed Pharmaceuticals, we also check how macroeconomic factors affect InMed Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Graham Number18.995.26208.7
Receivables Turnover15.8813.0310.07
Hype
Prediction
LowEstimatedHigh
0.265.2112.06
Details
Intrinsic
Valuation
LowRealHigh
0.234.5411.39
Details
Naive
Forecast
LowNextHigh
0.115.4112.25
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InMed Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InMed Pharmaceuticals' short interest history, or implied volatility extrapolated from InMed Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
FinTech Idea
FinTech
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
Impulse Idea
Impulse
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Semiconductor Idea
Semiconductor
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares
When determining whether InMed Pharmaceuticals is a strong investment it is important to analyze InMed Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact InMed Pharmaceuticals' future performance. For an informed investment choice regarding InMed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
230.4
Revenue Per Share
0.603
Quarterly Revenue Growth
(0.45)
Return On Assets
(0.39)
Return On Equity
(0.72)
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.